Hawaii Memory & Alzheimer’s Research Joins National Centers to Investigate VHB937 for Early Alzheimer’s Disease

Hawaii Memory & Alzheimer’s Research has joined leading academic institutions—including UCSF, UC San Diego, and the Cleveland Clinic—in a multicenter clinical trial investigating VHB937, a novel TREM2-stabilizing monoclonal antibody engineered to cross the blood–brain barrier and reduce neuroinflammation in Alzheimer’s…

Brainshuttle TM Launched in Hawaii! 

Brainshuttle TM Launched in Hawaii! 

Brainshuttle™ Launched in Hawaii!  Novel Alzheimer’s Drug Trontinemab with Brainshuttle™ Technology A new Alzheimer’s clinical study using the investigational drug trontinemab, engineered with Brainshuttle™ technology, is now accepting participants in Hawaii. This approach aims to achieve rapid amyloid clearance with…

©2026, Hawaii Pacific Neuroscience. All Rights Reserved.